Council Members in this Study Group: 633
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Harold BaysPresident and Medical Director
L-MARC Research Center![]()
Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all...
Clinical Professor of Medicine
UNIVERSITY OF CALIFORNIA, LOS ANGELES![]()
Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA...
David PortmanDirector
COLUMBUS CENTER FOR WOMENS HEALTH RESEARCH![]()
David Portman, MD, is Director and Principal Investigator of the Columbus Center for Women's Health Research. Dr. Portman is also a Clincial Investigator at The Ohio State University. He has conducted over 100 clinical studies in areas of contraception,...
Farhad ZangenehAssistant Clinical Professor of Medicine
THE GEORGE WASHINGTON UNIVERSITY - CC![]()
Farhad Zangeneh, MD, is an Assistant Clinical Professor of Medicine at George Washington University School of Medicine in District of Columbia. He is on the board of directors of ACCE and recently contributed to the AACE Diabetes guidelines. He is the...
Director of General Internal Medicine
SAINT LOUIS UNIVERSITY![]()
George Griffing, MD, is Professor of Internal Medicine at St. Louis University. Dr. Griffing's clinical expertise includes the diagnosis and treatment of diabetes. His research interests include the clinical investigation of inhaled insulin, nasal insulin...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Outsourcing of compassionate use of drugs?
January 18, 2008
No right to experimental drugs for dying patients: Supreme Court | news.yahoo.com
The Supreme Court has rejected the use of experimental drugs by the dying patients on the grounds that "The framers (of the US constitution) understood that the pursuit of life is an inalienable right that should not be abridged without due process of law." Over the years our patients with terminal illness have traveled outside the US to purchase hope when our management was offering none. Although in the majority of cases the hope was unjustified, the current decision will encourage healthcare providers residing outside the US to advertise for their services through the internet. The issue should be addressed by the legislators sooner rather than later. Drugs who improve quality of life, awaiting approval for survival indication or drugs looking promising in early clinical trials could be made available to dying patients with informed consent addressing our limitations.
Non-glycemic benefits of Rosigliatazone: too little to late?
July 10, 2006
Rosiglitazone May Delay Progression of Severe Diabetic Retinopathy | www.ophthalmologytimes.com
Reduction of proliferative rentinopathy in patients with Diabetes by Rosigliatzone.